Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
1998 ◽
Vol 352
(9138)
◽
pp. 1426-1432
◽
1998 ◽
Vol 10
(12)
◽
pp. 1063
2000 ◽
Vol 12
(2)
◽
pp. 251-253
◽
Keyword(s):
2004 ◽
Vol 287
(1-2)
◽
pp. 91-99
◽
Keyword(s):
Keyword(s):
Keyword(s):
2015 ◽
Vol 45
(4)
◽
pp. 389
◽